Contact this trialFirst, we need to learn more about you.
Acetylcholine Modulator
KarXT for Schizophrenia
Recruiting2 awardsPhase 3
Louisville, Kentucky
This trial is testing KarXT, a new medication, in people with schizophrenia who aren't doing well on their current treatments. The study will check if KarXT is safe to use over an extended period, if patients can handle it without bad side effects, and if it works well to control their symptoms.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service